Patient Reported Outcomes following initiation of Glucagon-like peptide-1 Receptor agonists in patients with type 2 Diabetes in a specialist endocrinology practice of the LMC diabetes registry: The PROGRESS-Diabetes study

Authors:

Abstract
No abstract available
Funding Information
  • Eli Lilly Canada

This publication has 19 references indexed in Scilit: